All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or Myeloma crowd.

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Why should chromosome 1 abnormalities be assessed in all patients with MM?

During the 63rd ASH Annual Meeting and Exposition, the Multiple Myeloma Hub was pleased to speak to Timothy M. Schmidt, University of Wisconsin-Madison, Madison, US. We asked, why should chromosome 1 abnormalities be assessed in all patients with multiple myeloma (MM)?

Why should chromosome 1 abnormalities be assessed in all patients with MM?

In this video, Schmidt discusses the importance and utility of assessing chromosome 1 abnormalities for prognosis of high-risk MM patients. He also highlights the importance of identifying patients with chromosomal abnormalities early.

 

Share: